RPL15 and pancreatic ductal adenocarcinoma: The expression of RPL15 varied with the type of cancer, and it was highly expressed in esophageal cancer, gastric cancer, hepatocellular carcinoma, and colon cancer, but lowly expressed in cutaneous squamous cell carcinoma and pancreatic ductal adenocarcinoma [61, 64–68].